Skip to main content
Caplight Logo









Dualyx

Dualyx

Private
BelgiumHealthcare & Life Scienceshttps://dualyx.com

Last Round

Series A

May 15, 2023

Total Funding Raised

$51.7M

Company Overview

Dualyx is a biotechnology company that develops next-generation immune modulators and Treg-based therapies for autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

Treg modulationTNFR2 agonistautoimmune disease therapyantibody therapybiologic drugnanobody technologyimmune modulationTNFR2regulatory T cellspre-clinical biotechfirst-in-class drugIND-enabling studiesinflammatory bowel diseaseIBDrheumatoid arthritisRA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dualyx Comparables

Compare Dualyx with similar companies based on industry and business-model similarity.

Dualyx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TRexBio
81%
Egle Therapeutics
79%
Mozart Therapeutics
78%

Dualyx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 15, 2023
SeedMar 1, 2020

Dualyx Investors

Notable investors and investment history

Dualyx investors
InvestorRounds
ForbionSeries A
Andera PartnersSeries A
Fountain Healthcare PartnersSeries A
V-Bio VenturesSeed, Series A
PMVSeed, Series A
BioGeneration VenturesSeed, Series A
BgvcatSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2020

    $8M raised from BioGeneration Ventures and others.

Dualyx Filings

Explore SEC and related filing metadata, where available.

Dualyx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dualyx's valuation, stock price, and market status.

Is Dualyx a public or private company?

Dualyx is a private company.

What is the current stock price of Dualyx?

Dualyx is a private company with no public stock price. No recent secondary market data is available.

How much is Dualyx worth (valuation)?

Valuation information for Dualyx is not publicly available.

Can I buy Dualyx stock?

Dualyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dualyx's last funding round?

Funding round information for Dualyx is not publicly available.

Who are the main investors in Dualyx?

Investor information for Dualyx is not publicly disclosed.

Will Dualyx IPO soon?

No public IPO plans have been announced for Dualyx.

How can I track Dualyx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dualyx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Year Founded2020
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?